Ordering Recommendation
Use for the detection of IgG antibodies against the spike protein (S1) of SARS-CoV-2 (COVID-19) that develop in response to natural infection with SARS-CoV-2 or from a COVID-19 vaccination. There are no current recommendations for assessing COVID-19 vaccine response.
Mnemonic
Methodology
Semi-Quantitative Chemiluminescent Immunoassay (CLIA)
Performed
Sun-Sat
Reported
Within 24 hours
New York DOH Approval Status
Specimen Required
Serum separator tube (SST). Also acceptable: lithium heparin.
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Refrigerated.
Specimens containing particulate material or otherwise obviously contaminated. Severely hemolyzed, heat-inactivated, severely icteric, or lipemic specimens. Postmortem specimens.
After separation from cells: Ambient: 72 hours; Refrigerated: 1 week; Frozen: 1 month (avoid repeated freeze/thaw cycles)
Reference Interval
Less than 1.00 Index Value | Negative |
Greater than or equal to 1.00 Index Value | Positive |
Interpretive Data
This test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA). In compliance with this authorization, please visit https://www.aruplab.com/infectious-disease/coronavirus/testing for more information and to access the applicable fact sheets.
Emergency Use Authorization (EUA)
Note
Hotline History
Hotline History
CPT Codes
86769
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3003649 | COVID-19 IgG Index by CIA | 94505-5 |
3003650 | COVID-19 IgG by CIA Interpretation | 94563-4 |
Aliases
- 2019-nCoV
- Coronavirus Disease -- 2019
- COVID Ab
- COVID Antibody
- COVID Antibody Test
- COVID-19 Illness
- COVID-2019
- COVID19 IgG Ab
- SARS-CoV-2